BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11891818)

  • 1. Comprehensive cytogenetic study by spectral karyotyping on blastic natural killer cell leukemia/lymphoma.
    Jyoko N; Kuroda J; Kimura S; Kobayashi Y; Yoshikawa T
    Am J Hematol; 2002 Mar; 69(3):234-5. PubMed ID: 11891818
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive natural killer cell leukemia/lymphoma: a comprehensive cytogenetic study by spectral karyotyping.
    Kuroda J; Kimura S; Akaogi T; Hayashi H; Nishida K; Kakazu N; Abe T
    Ann Hematol; 2000 Sep; 79(9):519-22. PubMed ID: 11043424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell lines.
    Tagawa H; Miura I; Suzuki R; Suzuki H; Hosokawa Y; Seto M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):175-85. PubMed ID: 11979551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.
    Siu LL; Wong KF; Chan JK; Kwong YL
    Am J Pathol; 1999 Nov; 155(5):1419-25. PubMed ID: 10550295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer-like T-cell leukaemia/lymphoma.
    Gupta V; Mills MJ; Eden AG
    Br J Haematol; 2001 Dec; 115(3):490. PubMed ID: 11736928
    [No Abstract]   [Full Text] [Related]  

  • 7. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.
    Kimura S; Kakazu N; Kuroda J; Akaogi T; Hayashi H; Nishida K; Abe T
    Ann Hematol; 2001 Apr; 80(4):228-31. PubMed ID: 11401089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+gamma/delta T cell leukemia/lymphoma: clinical, immunophenotypic and molecular aspects in an unusual case.
    de Souza MH; Hassan R; Stefanoff CG; Maioli MC; Diamond HR; Renault IZ
    Haematologica; 2003 Aug; 88(8):ECR27. PubMed ID: 12935986
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity.
    Sun T; Brody J; Susin M; Marino J; Teichberg S; Koduru P; Hall WW; Urmacher C; Hajdu SI
    Am J Surg Pathol; 1993 Dec; 17(12):1289-99. PubMed ID: 8238737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of cytogenetic research in childhood acute lymphoblastic leukemia.
    Raimondi SC
    Blood; 1993 May; 81(9):2237-51. PubMed ID: 8481506
    [No Abstract]   [Full Text] [Related]  

  • 11. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
    Zhang K; Prichard JW; Brown RE
    Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD56+ hematologic malignancies.
    Loughran TP
    Leuk Res; 1999 Jul; 23(7):675-6. PubMed ID: 10400189
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcription factor expression in cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
    Matsuo Y; Drexler HG; Harashima A; Okochi A; Shimizu N; Orita K
    Hum Cell; 2004 Jun; 17(2):85-92. PubMed ID: 15369140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T-cell lymphomas and "natural killer". Histopathologic, immunologic and molecular aspects].
    Kanavaros P; Gaulard P
    Ann Pathol; 1998 Oct; 18(4):299-314. PubMed ID: 9827221
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphoid disorders other than common acute lymphoblastic leukemia: background.
    Swansbury J
    Methods Mol Biol; 2003; 220():93-110. PubMed ID: 12744209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome Preparation for Acute Lymphoblastic Leukemia.
    Shago M
    Methods Mol Biol; 2017; 1541():19-31. PubMed ID: 27910011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natural killer-like T-cell lymphoma/leukemia--a case report and literature review].
    Zhang FK; Wang HJ; Wu YH; Dong SX; Li HQ; Yang DL; Chen HS; Chu YL
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):226-30. PubMed ID: 16875551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex cytogenetic abnormalities in T-lymphoblastic lymphoma: resolution by spectral karyotyping.
    Wan TS; Ma SK; Chan GC; Ching LM; Ha SY; Chan LC
    Cancer Genet Cytogenet; 2000 Apr; 118(1):24-7. PubMed ID: 10731586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell receptor gamma and delta junctional gene rearrangements as diagnostic and prognostic biomarker for T-cell acute lymphoblastic leukemia.
    Kode J; Dudhal N; Banavali S; Chiplunkar S
    Leuk Lymphoma; 2006 Apr; 47(4):769-70. PubMed ID: 16886283
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular genetics and malignant hemopathies. The current situation].
    Soler J
    Med Clin (Barc); 1992 Jan; 98(3):94-5. PubMed ID: 1552757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.